LFMM 2: Fast and Accurate Inference of Gene-Environment Associations in Genome-Wide Studies.


Journal

Molecular biology and evolution
ISSN: 1537-1719
Titre abrégé: Mol Biol Evol
Pays: United States
ID NLM: 8501455

Informations de publication

Date de publication:
01 04 2019
Historique:
pubmed: 19 1 2019
medline: 30 6 2019
entrez: 19 1 2019
Statut: ppublish

Résumé

Gene-environment association (GEA) studies are essential to understand the past and ongoing adaptations of organisms to their environment, but those studies are complicated by confounding due to unobserved demographic factors. Although the confounding problem has recently received considerable attention, the proposed approaches do not scale with the high-dimensionality of genomic data. Here, we present a new estimation method for latent factor mixed models (LFMMs) implemented in an upgraded version of the corresponding computer program. We developed a least-squares estimation approach for confounder estimation that provides a unique framework for several categories of genomic data, not restricted to genotypes. The speed of the new algorithm is several order faster than existing GEA approaches and then our previous version of the LFMM program. In addition, the new method outperforms other fast approaches based on principal component or surrogate variable analysis. We illustrate the program use with analyses of the 1000 Genomes Project data set, leading to new findings on adaptation of humans to their environment, and with analyses of DNA methylation profiles providing insights on how tobacco consumption could affect DNA methylation in patients with rheumatoid arthritis. Software availability: Software is available in the R package lfmm at https://bcm-uga.github.io/lfmm/.

Identifiants

pubmed: 30657943
pii: 5290100
doi: 10.1093/molbev/msz008
pmc: PMC6659841
doi:

Types de publication

Evaluation Study Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

852-860

Informations de copyright

© The Author(s) 2019. Published by Oxford University Press on behalf of the Society for Molecular Biology and Evolution.

Références

Mol Med Rep. 2018 Jan;17(1):193-199
pubmed: 29115427
Genome Biol. 2016 Jun 06;17(1):122
pubmed: 27268795
Mol Ecol. 2015 Mar;24(5):1031-46
pubmed: 25648189
Rheumatology (Oxford). 2004 Apr;43(4):435-41
pubmed: 14762224
Nat Methods. 2014 Mar;11(3):309-11
pubmed: 24464286
J Am Stat Assoc. 2008 Dec 1;103(484):1438-1456
pubmed: 21218139
Nat Rev Genet. 2013 Nov;14(11):807-20
pubmed: 24136507
Arthritis Res Ther. 2008;10(4):R98
pubmed: 18721452
Clin Cancer Res. 2004 Feb 1;10(3):938-43
pubmed: 14871970
Nat Genet. 2006 Aug;38(8):904-9
pubmed: 16862161
Genetics. 2015 Dec;201(4):1555-79
pubmed: 26482796
Nat Biotechnol. 2013 Feb;31(2):142-7
pubmed: 23334450
Genome Biol. 2014 Feb 04;15(2):R31
pubmed: 24495553
Heredity (Edinb). 2015 Jul;115(1):22-8
pubmed: 25690180
Mol Ecol. 2013 Mar;22(5):1383-99
pubmed: 23294205
Arthritis Rheum. 2007 Oct;56(10):3271-83
pubmed: 17907173
Arthritis Res Ther. 2014 Mar 05;16(2):R61
pubmed: 24594022
Scand J Immunol. 2014 Jun;79(6):410-4
pubmed: 24684517
Arthritis Res Ther. 2005;7(2):R217-29
pubmed: 15743468
Mol Biol Evol. 2013 Jul;30(7):1687-99
pubmed: 23543094
Drug Des Devel Ther. 2018 Apr 24;12:967-979
pubmed: 29731604
Genome Biol. 2017 Jan 27;18(1):19
pubmed: 28129774
Science. 2016 Oct 7;354(6308):54-59
pubmed: 27846491
Nat Rev Genet. 2011 Jul 12;12(8):529-41
pubmed: 21747404
PLoS One. 2009 May 28;4(5):e5721
pubmed: 19492092
Ann Stat. 2017 Oct;45(5):1863-1894
pubmed: 31439967
Genetics. 2013 Sep;195(1):205-20
pubmed: 23821598
Int Immunopharmacol. 2017 May;46:141-145
pubmed: 28282578
Mol Ecol. 2014 Apr;23(8):2006-19
pubmed: 24611968
Mol Ecol. 2015 Sep;24(17):4348-70
pubmed: 26184487
Nat Rev Genet. 2018 Mar;19(3):129-147
pubmed: 29129922
Biometrics. 1999 Dec;55(4):997-1004
pubmed: 11315092
Nature. 2015 Oct 1;526(7571):68-74
pubmed: 26432245
PLoS Genet. 2009 Oct;5(10):e1000686
pubmed: 19834557
PLoS Genet. 2007 Sep;3(9):1724-35
pubmed: 17907809

Auteurs

Kevin Caye (K)

Université Grenoble-Alpes, Centre National de la Recherche Scientifique, Grenoble INP, TIMC-IMAG CNRS UMR 5525, Grenoble 38000, France.

Basile Jumentier (B)

Université Grenoble-Alpes, Centre National de la Recherche Scientifique, Grenoble INP, TIMC-IMAG CNRS UMR 5525, Grenoble 38000, France.

Johanna Lepeule (J)

Université Grenoble-Alpes, Institut National de la Santé et de la Recherche Médicale, Centre National de la Recherche Scientifique, Institute for Advanced Biosciences, INSERM U 1209 - CNRS UMR 5309, Grenoble 38000, France.

Olivier François (O)

Université Grenoble-Alpes, Centre National de la Recherche Scientifique, Grenoble INP, TIMC-IMAG CNRS UMR 5525, Grenoble 38000, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH